

Two years ago, chief executive David Brennan said more than 10,000 jobs would be lost by 2014, the newspaper said. The target may be extended significantly when the company announces its annual results on Feb. 2, the newspaper said. The drugmaker may spend more than $3 billion on buying back shares this year, the paper said, citing analysts.
Ver
Ver también:
‘Axe hovers over AstraZeneca jobs’
No hay comentarios:
Publicar un comentario